ATOPE Trial
Cross-source consensus on ATOPE Trial from 1 sources and 6 claims.
1 sources · 6 claims
Other
Other
Highlighted claims
- The ATOPE study is a single-centre prospective interventional trial conducted at IFEM Endo in Bordeaux, France. — ATOPE study protocol: a randomised controlled trial comparing cystectomy and plasma vapourisation in endometriomas under 6 cm, with an observational arm for sclerotherapy in larger cysts
- ATOPE combines a two-arm randomized controlled trial with a parallel non-randomized observational cohort. — ATOPE study protocol: a randomised controlled trial comparing cystectomy and plasma vapourisation in endometriomas under 6 cm, with an observational arm for sclerotherapy in larger cysts
- The RCT assigns women with 2–6 cm endometriomas to plasma vapourisation or cystectomy. — ATOPE study protocol: a randomised controlled trial comparing cystectomy and plasma vapourisation in endometriomas under 6 cm, with an observational arm for sclerotherapy in larger cysts
- Recruitment is planned to begin in October 2025 and close in December 2032. — ATOPE study protocol: a randomised controlled trial comparing cystectomy and plasma vapourisation in endometriomas under 6 cm, with an observational arm for sclerotherapy in larger cysts
- Randomisation is performed intraoperatively using Dotter.science with 1:1 allocation and no stratification. — ATOPE study protocol: a randomised controlled trial comparing cystectomy and plasma vapourisation in endometriomas under 6 cm, with an observational arm for sclerotherapy in larger cysts
- Each participant is followed for 24 months, giving the study a total duration of 108 months. — ATOPE study protocol: a randomised controlled trial comparing cystectomy and plasma vapourisation in endometriomas under 6 cm, with an observational arm for sclerotherapy in larger cysts